Düsseldorf/Amsterdam, 20 September 2022 – As of September 2022 Holland Capital is a full member of The German Private Equity and Venture Capital Association (BVK). With this membership, Holland Capital confirms its commitment to the German private equity market.
BVK: face and voice of the private equity industry
BVK is the face and voice of the private equity industry in Germany, they campaign for improvements to the fiscal environment and for easier access to private equity so that even more companies in Germany can benefit from private equity. BVK takes a stand on policy issues and the media in an effort to underline how important private equity is for the German economy. They observe the market and analyse its trends, as private equity can be a growth engine for innovation, start-ups and SME’s. www.bvkap.de
Holland Capital is committed to the German market
Ewout Prins, managing partner Holland Capital, “Holland Capital has been active for over 40 years as a private equity investor within the Healthcare and Technology sectors in the Dutch market. We see interesting opportunities in the German market for our investment strategy. To support the expansion of our activities into the German market, we opened our Düsseldorf office last year. We look forward to working with German entrepreneurs, investors and advisers. As such, we are pleased to have become member of the BVK. We shall be happy to contribute to the German Private Equity industry”.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs in the relevant growth markets and has her offices in Amsterdam (NL) and Düsseldorf (D).
Supermetrics acquires leading CDP, Relay42 to redefine the future of Marketing Intelligence
Our portfolio company Relay42, a leading real-time Customer Data Platform (CDP), has been acquired by Supermetrics, the leading Marketing Intelligence Platform. Holland Capital actively supported Relay42 in both operational and strategic development since becoming a shareholder in 2015.
Award-winning design studio flora&faunavisions joins The Storytelling Company
Our portfolio company The Storytelling Company adds the award-winning Berlin-based visual design studio flora&faunavisions to its portfolio of groundbreaking businesses
Holland Capital takes on the Alps for ‘Kinderen van de Voedselbank’ Foundation
This year, a group of sporty colleagues from Holland Capital are taking on a heroic challenge: the Marmotte – one of the toughest and most iconic cycling tours in the French Alps.
Insights from Holland Capital and Deloitte’s webinar
Last week, in partnership with Deloitte, we hosted an engaging and inspiring ESG webinar for our portfolio companies.
Gullimex attracts investor Holland Capital for further growth
Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.
Our portfolio company Sirius Medical is partnering with Mammotome
Our portfolio company Sirius Medical, the innovator of Surgical Marker Navigation and Mammotome, a globally recognized leader in breast care, are proud to announce an exclusive distribution agreement for the United States and Germany.

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01